Sen. Markey to DoE: What About the James Doyle Case?
Senator Edward J. Markey asked the Secretary of Energy this week to expedite the investigation of the firing of James Doyle from Los Alamos National Laboratory, which occurred after Doyle published an analysis critical of U.S. nuclear weapons policy.
“I write to urge you in the strongest possible terms to quickly conclude your investigation into the recent termination of Dr. James E. Doyle, a nuclear security and non-proliferation specialist who had been employed at the Los Alamos National Laboratory (LANL) for 17 years,” Sen. Markey wrote.
“Dr. Doyle was terminated after an article he published crticizing the deterrence value of nuclear weapons was retroactively classified. At best, the Department of Energy’s (DOE) classification procedures are too vague to be uniformly applied. At worst, it appears that these classification procedures were used to silence and retaliate against those who express dissenting opinions,” he wrote.
The Doyle case generated significant controversy among his colleagues and others concerned with nuclear security policy.
In response to public concerns, the Department of Energy said it had initiated an Inspector General review of the case. But there has been no known follow-up to date.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.